NeoStem Inc Stock Nyse
Equities
NBS
US6406503051
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 22M |
---|---|---|---|---|---|
Net income 2024 * | -25M | Net income 2025 * | -30M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.86
x | P/E ratio 2025 * |
-0.99
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.86% |
Latest transcript on NeoStem Inc
1st Jan change | Capi. | |
---|---|---|
+1.78% | 42.75B | |
+47.70% | 41.61B | |
+12.16% | 41.34B | |
-8.83% | 26.59B | |
+7.50% | 25.49B | |
-23.09% | 18.12B | |
+30.49% | 12.24B | |
-1.95% | 11.76B | |
+8.32% | 11B |
- Stock Market
- Equities
- LSTA Stock
- NBS Stock